Lanreotide Acetate CAS NO.108736-35-2

lanreotide descriptions

lanreotide (inn) is a medication used in the management of acromegaly and symptoms caused byneuroendocrine tumors, most notably carcinoid syndrome. it is a long-acting analogue ofsomatostatin, likeoctreotide. its sequence is h-d-2nal-cys(1)-tyr-d-trp-lys-val-cys(1)-thr-nh2.

lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (tsh), insulinand glucagon. lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. however, while somatostatin is quickly broken down in the body (within minutes),[2] lanreotide has a much longer half-life, and produces far more prolonged effects

cautions: the products we provide are for research or indutry production,forbidden for private consumption.